Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Krystal Biotech (KRYS) Change in Cash: 2016-2024

Historic Change in Cash for Krystal Biotech (KRYS) over the last 9 years, with Dec 2024 value amounting to -$13.5 million.

  • Krystal Biotech's Change in Cash rose 37.60% to $38.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 2470.76%. This contributed to the annual value of -$13.5 million for FY2024, which is 106.85% down from last year.
  • Latest data reveals that Krystal Biotech reported Change in Cash of -$13.5 million as of FY2024, which was down 106.85% from $196.4 million recorded in FY2023.
  • Krystal Biotech's 5-year Change in Cash high stood at $196.4 million for FY2023, and its period low was -$179.3 million during FY2022.
  • Its 3-year average for Change in Cash is $1.2 million, with a median of -$13.5 million in 2024.
  • In the last 5 years, Krystal Biotech's Change in Cash plummeted by 345.76% in 2022 and then spiked by 209.52% in 2023.
  • Krystal Biotech's Change in Cash (Yearly) stood at $80.8 million in 2020, then dropped by 9.63% to $73.0 million in 2021, then tumbled by 345.76% to -$179.3 million in 2022, then surged by 209.52% to $196.4 million in 2023, then tumbled by 106.85% to -$13.5 million in 2024.